A High Risk Group in the Modified National Institutes of Health Consensus Criteria for the Gastrointestinal Stromal Tumor: A Clear Indication of the Adjuvant Imatinib

Detalles Bibliográficos
Autor principal: Chang, Dong Kyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association for the Study of Intestinal Diseases 2014
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204718/
https://www.ncbi.nlm.nih.gov/pubmed/25349590
http://dx.doi.org/10.5217/ir.2014.12.3.176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204718/
https://www.ncbi.nlm.nih.gov/pubmed/25349590
http://dx.doi.org/10.5217/ir.2014.12.3.176

Ejemplares similares